eNewsletter - TCRN, CONCERT & Cancer CAG
No images? Click here
The Cancer Clinical Academic Group is now proudly working with Translational Cancer Research Centre partners to bring you the latest news, grant opportunities, and events from our combined network
Uniting cancer research into a globally-leading partnership to deliver continuing evidence-based practice in diagnosis, intervention, and support
LATEST NEWS
UNSW Medicine/SPHERE Early/mid-career cancer seed grant results
Maridulu Budyari Gumal (SPHERE) Cancer Clinical Academic Group has committed $100K in new seed grants for two interdisciplinary projects led by early/mid-career researchers (EMCRs) to be undertaken in 2021. Congratulations to the successful awardees and their teams:
- Dr Trang Pham (Liverpool Hospital, SWSLHD and UNSW Sydney): Targeting cancer heterogeneity with ultra-high field MRI and radiotherapy using machine learning
- Dr Liz Caldon (Garvan Institute of Medical Research and UNSW Sydney): Targeting FGF fusions in previously untreatable cancers: A new OMICS approach for personalised cancer medicine.
World Cancer Day event 4th February 2021: Cancer CAG, CONCERT and TCRN
Thanks go to Prof Jeff Dunn AO, Prof Michael Barton AO, Prof Geoff Delaney and a panel of an inspiring cancer experts and community members at yesterday's World Cancer Day webinar.
CONCERT Researchers in World Cancer Day campaign
Members of CONCERT's Psycho-Oncology Research Group, led by Prof Afaf Girgis, featured in a World Cancer Day campaign supported by SPHERE Knowledge Translation.
Read more
CINSW Translational Research Grant
Please note members of the Cancer Cancer Clinical Academic Group, Maridulu Budyari Gumal (SPHERE), CONCERT and the TCRN do not need to opt in to be included in the member group for the upcoming Translational Research Grant. We already have your details and will contact you personally if we need further information.
Liver cancer ‘signature’ in gut holds clues to cancer risk
People with non-alcohol-related liver cancer have a unique gut microbiome profile which could help predict disease risk, a UNSW Sydney study has found.
Read more
Global demand for cancer surgery set to surge
A new modelling study led by UNSW predicts demand for cancer surgery will rise by 52 per cent within two decades, with low-income countries bearing the greatest burden.
Read more
Human pancreatic cancer model offers new opportunities for testing drugs
UNSW scientists have grown human pancreatic cancer tumours in the lab – their model is the first of its kind, with important future clinical implications.
New discovery in breast cancer treatment
The Garvan Institute of Medical Research contributed to an international study that has found new evidence about the positive role of androgens in breast cancer treatment with immediate implications for women with estrogen receptor-driven metastatic disease.
CONCERT’s Member of the month: Professor Shalini Vinod
If anyone has got work/life balance right, it’s Professor Shalini Vinod, radiation oncologist at Liverpool’s Cancer Therapy Centre in Liverpool Hospital.
TCRN PhD candidate profiles
Recent articles from TCRN Members
Read more
GRANTS
NSW Health Medical Devices Fund
The Medical Devices Fund aims to provide support to individuals, companies, public and private hospitals, medical research institutes, universities and the medical devices industry, to take local innovation to market.
Deadline: 1 March 2021
Read more
MRFF Funding Opportunities
- 2020 International Clinical Trial Collaborations Grant Opportunity Round 2 Deadline: 3 Mar 2021
- MRFF – Stem Cell Therapies Mission – 2020 Stem Cell Therapies Grant Opportunity Deadline: 3 March 2021
- MRFF - Genomics Health Futures Mission - 2020 Genomics Health Futures Mission Grant Opportunity Deadline: 3 March 2021
- MRFF – EPCDR Initiative– 2020 Improving Diagnosis in Cancers with Low Survival Rates Grant Opportunity Deadline: 10 March 2021
- MRFF – Emerging Priorities and Consumer Driven Research Initiative – 2020 Paediatric Cancer Grant Opportunity Deadline: 10 March 2021
NHMRC 2021 Funding Opportunities
- 2021 Investigator Grants Deadline: 31 March 2021
- Partnership Project 2021 PRC1 Deadline: 7 April 2021
AWARDS, TRAINING AND RESOURCES
The Prime Minister's Prizes for Science
The Science Prizes recognise the achievements and success of Australian scientists and innovators to both Australia and internationally. Nominations are open for prizes across five categories, with a total prize pool of up to $750,000.
Deadline: 9 March 2021
SEMINARS AND EVENTS
Randwick Precinct Cancer Roundtable
Long-term Neurotoxicity in Cancer Survivors presented by A/Prof Susanna Park, facilitated by Prof David Goldstein.
When: 9 February 2021
CONCERT roundtable: Immunotherapy
Facilitated and presented by A/Prof Daniel Brungs and Dr Tamiem Adam.
When: 10 February 2021
TCRN Consumer Workshop
This workshop provides a valuable opportunity to engage with a group of consumers and present your research plan for their input. Secure your place by 8 February.
When: 2 March 2021
Save the date! Cancer Immunology Workshop
Further details to follow shortly.
When: 21 May 2021
ABOUT US
TCRN
The Translational Cancer Research Network (TCRN) is a translational cancer research centre program funded by the Cancer Institute NSW and is a collaborative and interactive cancer research community based in the South East of Sydney, with links to cancer services and researchers in inner and southern Sydney, and Albury. It was formed to create an innovative and supportive environment for the translation of cancer research into improvements in patient care.
CONCERT
The Centre for Oncology Education, Research and Training (CONCERT) is a translational research centre program funded by the Cancer Insitute NSW. CONCERT exists to bring together the knowledge and expertise of cancer health professionals and researchers to facilitate translation of research generated evidence into practice to achieve better outcomes for those affected by cancer.
Cancer CAG
The Cancer Clinical Academic Group (Cancer CAG) brings together clinicians and researchers from three universities, four cancer services (with six major treatment facilities) and three Medical Research Institutes. Our combined research strength spans the translational medicine spectrum of bench to bedside and health service delivery.
Working with TCRC partners, our network extends to all of the organisations below.
Connect with us!
CONCERT
Cancer CAG
TCRN
